Compounders sue FDA over end of semaglutide shortage
Drug compounders have sued the FDA to put the weight loss and diabetes drug semaglutide back on an official shortage list, fighting a regulatory decision that imperils the companies' business. “If ever an agency action ...
Drug compounders have sued the FDA to put the weight loss and diabetes drug semaglutide back on an official shortage list, fighting a regulatory decision that imperils the companies' business.
“If ever an agency action ...
